Skip to main content
Top
Published in: BMC Medicine 1/2010

Open Access 01-12-2010 | Research article

An evaluation of inflammatory gene polymorphisms in sibships discordant for premature coronary artery disease: the GRACE-IMMUNE study

Authors: Benjamin D Brown, Jérémie Nsengimana, Jennifer H Barrett, Richard A Lawrence, Lori Steiner, Suzanne Cheng, D Timothy Bishop, Nilesh J Samani, Stephen G Ball, Anthony J Balmforth, Alistair S Hall

Published in: BMC Medicine | Issue 1/2010

Login to get access

Abstract

Background

Inflammatory cytokines play a crucial role in coronary artery disease (CAD). We investigated the association between 48 coding and three non-coding single nucleotide polymorphisms (SNPs) from 35 inflammatory genes and the development of CAD, using a large discordant sibship collection (2699 individuals in 891 families).

Methods

Family-based association tests (FBAT) and conditional logistic regression (CLR) were applied to single SNPs and haplotypes and, in CLR, traditional risk factors of CAD were adjusted for.

Results

An association was observed between CAD and a common three-locus haplotype in the interleukin one (IL-1) cluster with P = 0.006 in all CAD cases, P = 0.01 in myocardial infarction (MI) cases and P = 0.0002 in young onset CAD cases (<50 years). The estimated odds ratio (OR) per copy of this haplotype is 1.21 (95% confidence interval [95CI] = 1.04 - 1.40) for CAD; 1.30 (95CI = 1.09 - 1.56) for MI and 1.50 (95CI = 1.22 - 1.86) for young onset CAD. When sex, smoking, hypertension and hypercholesterolaemia were adjusted for, the haplotype effect remained nominally significant (P = 0.05) in young onset CAD cases, more so (P = 0.002) when hypercholesterolaemia was excluded. As many as 82% of individuals affected by CAD had hypercholesterolaemia compared to only 29% of those unaffected, making the two phenotypes difficult to separate.

Conclusion

Despite the multiple hypotheses tested, the robustness of family design to population confoundings and the consistency with previous findings increase the likelihood of true association. Further investigation using larger data sets is needed in order for this to be confirmed.
See the related commentary by Keavney: http://​www.​biomedcentral.​com/​1741-7015/​8/​6
Appendix
Available only for authorised users
Literature
1.
go back to reference Ross R: Atherosclerosis-an inflammatory disease. N Engl J Med. 1999, 340: 115-125. 10.1056/NEJM199901143400207.CrossRefPubMed Ross R: Atherosclerosis-an inflammatory disease. N Engl J Med. 1999, 340: 115-125. 10.1056/NEJM199901143400207.CrossRefPubMed
2.
go back to reference Lusis JA, Mar R, Pajukanta P: Genetics of atherosclerosis. Annu Rev Genomics Hum Genet. 2004, 5: 189-218. 10.1146/annurev.genom.5.061903.175930.CrossRefPubMed Lusis JA, Mar R, Pajukanta P: Genetics of atherosclerosis. Annu Rev Genomics Hum Genet. 2004, 5: 189-218. 10.1146/annurev.genom.5.061903.175930.CrossRefPubMed
3.
go back to reference Barcellos LF, Begovich AB, Reynolds RL, Caillier SJ, Brassat D, Schmidt S, Grams SE, Walker K, Steiner LL, Cree BAC, Stillman A, Lincoln RR, Pericak-Vance MA, Haines JL, Erlich HA, Hauser SL, Oksenberg JR: Linkage and association with the NOS2A locus on chromosome 17q11 in multiple sclerosis. Ann Neurol. 2004, 55: 793-800. 10.1002/ana.20092.CrossRefPubMed Barcellos LF, Begovich AB, Reynolds RL, Caillier SJ, Brassat D, Schmidt S, Grams SE, Walker K, Steiner LL, Cree BAC, Stillman A, Lincoln RR, Pericak-Vance MA, Haines JL, Erlich HA, Hauser SL, Oksenberg JR: Linkage and association with the NOS2A locus on chromosome 17q11 in multiple sclerosis. Ann Neurol. 2004, 55: 793-800. 10.1002/ana.20092.CrossRefPubMed
4.
go back to reference Abecasis GR, Cherny SS, Cookson WO, Cardon LR: GRR: graphical representation of relationship errors. Bioinformatics. 2001, 17: 742-743. 10.1093/bioinformatics/17.8.742.CrossRefPubMed Abecasis GR, Cherny SS, Cookson WO, Cardon LR: GRR: graphical representation of relationship errors. Bioinformatics. 2001, 17: 742-743. 10.1093/bioinformatics/17.8.742.CrossRefPubMed
5.
go back to reference Goring HH, Ott J: Relationship estimation in affected sib pair analysis of late-onset diseases. Eur J Hum Genet. 1997, 5: 69-77.PubMed Goring HH, Ott J: Relationship estimation in affected sib pair analysis of late-onset diseases. Eur J Hum Genet. 1997, 5: 69-77.PubMed
6.
go back to reference Boehnke M: Allele frequency estimation from data on relatives. Am J Hum Genet. 1991, 48: 22-25.PubMed Boehnke M: Allele frequency estimation from data on relatives. Am J Hum Genet. 1991, 48: 22-25.PubMed
7.
go back to reference Rabinowitz D, Laird NM: A unified approach to adjusting association tests for population admixture with arbitrary pedigree structure and arbitrary missing marker information. Hum Hered. 2000, 50: 211-223. 10.1159/000022918.CrossRefPubMed Rabinowitz D, Laird NM: A unified approach to adjusting association tests for population admixture with arbitrary pedigree structure and arbitrary missing marker information. Hum Hered. 2000, 50: 211-223. 10.1159/000022918.CrossRefPubMed
8.
go back to reference Lake SL, Blacker D, Laird NM: Family-based tests of association in presence of linkage. Am J Hum Genet. 2000, 67: 1515-1525. 10.1086/316895.CrossRefPubMed Lake SL, Blacker D, Laird NM: Family-based tests of association in presence of linkage. Am J Hum Genet. 2000, 67: 1515-1525. 10.1086/316895.CrossRefPubMed
9.
go back to reference STATA Corp: Stata Statistical Software: Release 9. TX: StataCorp LP. 2005 STATA Corp: Stata Statistical Software: Release 9. TX: StataCorp LP. 2005
10.
go back to reference Siegmund KD, Langholz B, Kraft P, Thomas DC: Testing linkage disequilibrium in sibships. Am J Hum Genet. 2000, 67: 244-248. 10.1086/302973.CrossRefPubMed Siegmund KD, Langholz B, Kraft P, Thomas DC: Testing linkage disequilibrium in sibships. Am J Hum Genet. 2000, 67: 244-248. 10.1086/302973.CrossRefPubMed
11.
go back to reference Nsengimana J, Barrett JH: Power, validity, bias and robustness of family-based association analysis methods in the presence of linkage for late onset diseases. Ann Hum Genet. 2008, 72: 793-800. 10.1111/j.1469-1809.2008.00475.x.CrossRefPubMed Nsengimana J, Barrett JH: Power, validity, bias and robustness of family-based association analysis methods in the presence of linkage for late onset diseases. Ann Hum Genet. 2008, 72: 793-800. 10.1111/j.1469-1809.2008.00475.x.CrossRefPubMed
12.
go back to reference Zhang K, Sun F, Zhao H: HAPLORE: a program for haplotype reconstruction in general pedigrees without recombination. Bioinformatics. 2005, 21: 90-103. 10.1093/bioinformatics/bth388.CrossRefPubMed Zhang K, Sun F, Zhao H: HAPLORE: a program for haplotype reconstruction in general pedigrees without recombination. Bioinformatics. 2005, 21: 90-103. 10.1093/bioinformatics/bth388.CrossRefPubMed
13.
go back to reference Zaykin DV, Westfall PH, Young SS, Karnoub MA, Wagner MJ, Ehm MG: Testing association of statistically inferred haplotypes with discrete and continuous traits in samples of unrelated individuals. Hum Hered. 2002, 53: 79-91. 10.1159/000057986.CrossRefPubMed Zaykin DV, Westfall PH, Young SS, Karnoub MA, Wagner MJ, Ehm MG: Testing association of statistically inferred haplotypes with discrete and continuous traits in samples of unrelated individuals. Hum Hered. 2002, 53: 79-91. 10.1159/000057986.CrossRefPubMed
14.
go back to reference Freedman ML, Reich D, Penney KL, McDonald GJ, Mignault AA, Patterson N, Gabriel SB, Topol EJ, Smoller JW, Pato CN, Pato MT, Petryshen TL, Kolonel LN, Lander ES, Sklar P, Henderson B, Hirschhorn JN, Altshuler D: Assessing the impact of population stratification on genetic association studies. Nat Genet. 2004, 36: 388-393. 10.1038/ng1333.CrossRefPubMed Freedman ML, Reich D, Penney KL, McDonald GJ, Mignault AA, Patterson N, Gabriel SB, Topol EJ, Smoller JW, Pato CN, Pato MT, Petryshen TL, Kolonel LN, Lander ES, Sklar P, Henderson B, Hirschhorn JN, Altshuler D: Assessing the impact of population stratification on genetic association studies. Nat Genet. 2004, 36: 388-393. 10.1038/ng1333.CrossRefPubMed
15.
go back to reference Isoda K, Sawada S, Ayaori M, Matsuki T, Horai R, Kagata Y, Miyazaki K, Kusuhara M, Okazaki M, Matsubara O, Iwakura Y, Ohsuzu F: Deficiency of interleukin-1 receptor antagonist deteriorates fatty liver and cholesterol metabolism in hypercholesterolemic mice. J Biol Chem. 2005, 280: 7002-7009. 10.1074/jbc.M412220200.CrossRefPubMed Isoda K, Sawada S, Ayaori M, Matsuki T, Horai R, Kagata Y, Miyazaki K, Kusuhara M, Okazaki M, Matsubara O, Iwakura Y, Ohsuzu F: Deficiency of interleukin-1 receptor antagonist deteriorates fatty liver and cholesterol metabolism in hypercholesterolemic mice. J Biol Chem. 2005, 280: 7002-7009. 10.1074/jbc.M412220200.CrossRefPubMed
16.
go back to reference Kirii H, Niwa T, Yamada Y, Wada H, Saito K, Iwakura Y, Asano M, Moriwaki H, Seishima M: Lack of interleukin-1 beta decreases the severity of atherosclerosis in ApoE-deficient mice. Arterioscler Thromb Vasc Biol. 2003, 23: 656-660. 10.1161/01.ATV.0000064374.15232.C3.CrossRefPubMed Kirii H, Niwa T, Yamada Y, Wada H, Saito K, Iwakura Y, Asano M, Moriwaki H, Seishima M: Lack of interleukin-1 beta decreases the severity of atherosclerosis in ApoE-deficient mice. Arterioscler Thromb Vasc Biol. 2003, 23: 656-660. 10.1161/01.ATV.0000064374.15232.C3.CrossRefPubMed
17.
go back to reference Waehre T, Yndestad A, Smith C, Haug T, Tunheim SH, Gullestad L, Froland SS, Semb AG, Aukrust P, Damas JK: Increased expression of interleukin-1 in coronary artery disease with downregulatory effects of hmg-coa reductase inhibitors. Circulation. 2004, 109: 1966-1972. 10.1161/01.CIR.0000125700.33637.B1.CrossRefPubMed Waehre T, Yndestad A, Smith C, Haug T, Tunheim SH, Gullestad L, Froland SS, Semb AG, Aukrust P, Damas JK: Increased expression of interleukin-1 in coronary artery disease with downregulatory effects of hmg-coa reductase inhibitors. Circulation. 2004, 109: 1966-1972. 10.1161/01.CIR.0000125700.33637.B1.CrossRefPubMed
18.
go back to reference Ikonomidis I, Lekakis JP, Nikolaou M, Paraskevaidis I, Andreadou I, Kaplanoglou T, Katsimbri P, Skarantavos G, Soucacos PN, Kremastinos DT: Inhibition of interleukin-1 by anakinra improves vascular and left ventricular function in patients with rheumatoid arthritis. Circulation. 2008, 117: 2662-2669. 10.1161/CIRCULATIONAHA.107.731877.CrossRefPubMed Ikonomidis I, Lekakis JP, Nikolaou M, Paraskevaidis I, Andreadou I, Kaplanoglou T, Katsimbri P, Skarantavos G, Soucacos PN, Kremastinos DT: Inhibition of interleukin-1 by anakinra improves vascular and left ventricular function in patients with rheumatoid arthritis. Circulation. 2008, 117: 2662-2669. 10.1161/CIRCULATIONAHA.107.731877.CrossRefPubMed
19.
go back to reference Abbate A, Salloum FN, Vecile E, Das A, Hoke NN, Straino S, Biondi-Zoccai GG, Houser JE, Qureshi IZ, Ownby ED, Gustini E, Biasucci LM, Severino A, Capogrossi MC, Vetrovec GW, Crea F, Baldi A, Kukreja RC, Dobrina A: Anakinra, a recombinant human interleukin-1 receptor antagonist, inhibits apoptosis in experimental acute myocardial infarction. Circulation. 2008, 117: 2670-83. 10.1161/CIRCULATIONAHA.107.740233.CrossRefPubMed Abbate A, Salloum FN, Vecile E, Das A, Hoke NN, Straino S, Biondi-Zoccai GG, Houser JE, Qureshi IZ, Ownby ED, Gustini E, Biasucci LM, Severino A, Capogrossi MC, Vetrovec GW, Crea F, Baldi A, Kukreja RC, Dobrina A: Anakinra, a recombinant human interleukin-1 receptor antagonist, inhibits apoptosis in experimental acute myocardial infarction. Circulation. 2008, 117: 2670-83. 10.1161/CIRCULATIONAHA.107.740233.CrossRefPubMed
20.
go back to reference Crossman DC, Morton AC, Gunn JP, Greenwood JP, Hall AS, Fox KA, Lucking AJ, Flather MD, Lees B, Foley CE: Investigation of the effect of interleukin-1 receptor antagonist (IL-1ra) on markers of inflammation in non-ST elevation acute coronary syndromes (the MRC-ILA-HEART Study). Trials. 2008, 9: 8-10.1186/1745-6215-9-8.CrossRefPubMed Crossman DC, Morton AC, Gunn JP, Greenwood JP, Hall AS, Fox KA, Lucking AJ, Flather MD, Lees B, Foley CE: Investigation of the effect of interleukin-1 receptor antagonist (IL-1ra) on markers of inflammation in non-ST elevation acute coronary syndromes (the MRC-ILA-HEART Study). Trials. 2008, 9: 8-10.1186/1745-6215-9-8.CrossRefPubMed
21.
go back to reference Momiyama Y, Hirano R, Taniguchi H, Nakamura H, Ohsuzu F: Effects of interleukin-1 gene polymorphisms on the development of coronary artery disease associated with Chlamydia pneumoniae infection. J Am Coll Cardiol. 2001, 38: 712-717. 10.1016/S0735-1097(01)01438-3.CrossRefPubMed Momiyama Y, Hirano R, Taniguchi H, Nakamura H, Ohsuzu F: Effects of interleukin-1 gene polymorphisms on the development of coronary artery disease associated with Chlamydia pneumoniae infection. J Am Coll Cardiol. 2001, 38: 712-717. 10.1016/S0735-1097(01)01438-3.CrossRefPubMed
22.
go back to reference Vohnout B, Di Castelnuovo CA, Trotta R, D'Orazi A, Panniteri G, Montali A, Donati MB, Arca M, Iacoviello L: Interleukin-1 gene cluster polymorphisms and risk of coronary artery disease. Haematologica. 2003, 88: 54-60.PubMed Vohnout B, Di Castelnuovo CA, Trotta R, D'Orazi A, Panniteri G, Montali A, Donati MB, Arca M, Iacoviello L: Interleukin-1 gene cluster polymorphisms and risk of coronary artery disease. Haematologica. 2003, 88: 54-60.PubMed
23.
go back to reference Iacoviello L, Di Castelnuovo A, Gattone M, Pezzini A, Assanelli D, Lorenzet R, Del Zotto E, Colombo M, Napoleone E, Amore C, D'Orazio A, Padovani A, de Gaetano G, Giannuzzi P, Donati MB, IGIGI Investigators: Polymorphisms of the interleukin-1 beta gene affect the risk of myocardial infarction and ischaemic stroke at young age and the response of mononuclear cells to stimulation in vitro. Arterioscler Thromb Vasc Biol. 2005, 25: 222-227.PubMed Iacoviello L, Di Castelnuovo A, Gattone M, Pezzini A, Assanelli D, Lorenzet R, Del Zotto E, Colombo M, Napoleone E, Amore C, D'Orazio A, Padovani A, de Gaetano G, Giannuzzi P, Donati MB, IGIGI Investigators: Polymorphisms of the interleukin-1 beta gene affect the risk of myocardial infarction and ischaemic stroke at young age and the response of mononuclear cells to stimulation in vitro. Arterioscler Thromb Vasc Biol. 2005, 25: 222-227.PubMed
24.
go back to reference Oda K, Tanaka N, Arai T, Araki J, Song Y, Zhang L, Kuchiba A, Hosoi T, Shirasawa T, Muramatsu M, Sawabe M: Polymorphisms in pro- and anti-inflammatory cytokine genes and susceptibility to atherosclerosis: a pathological study of 1503 consecutive autopsy cases. Hum Mol Genet. 2007, 16: 92-599. Oda K, Tanaka N, Arai T, Araki J, Song Y, Zhang L, Kuchiba A, Hosoi T, Shirasawa T, Muramatsu M, Sawabe M: Polymorphisms in pro- and anti-inflammatory cytokine genes and susceptibility to atherosclerosis: a pathological study of 1503 consecutive autopsy cases. Hum Mol Genet. 2007, 16: 92-599.
25.
go back to reference Chen H, Wilkins LM, Aziz N, Cannings C, Wyllie DH, Bingle C, Rogus J, Beck JD, Offenbacher S, Cork MJ, Rafie-Kolpin M, Hsieh CM, Kornman KS, Duff GW: Single nucleotide polymorphisms in the human interleukin-1B gene affect transcription according to haplotype context. Hum Mol Genet. 2006, 15: 519-529. 10.1093/hmg/ddi469.CrossRefPubMed Chen H, Wilkins LM, Aziz N, Cannings C, Wyllie DH, Bingle C, Rogus J, Beck JD, Offenbacher S, Cork MJ, Rafie-Kolpin M, Hsieh CM, Kornman KS, Duff GW: Single nucleotide polymorphisms in the human interleukin-1B gene affect transcription according to haplotype context. Hum Mol Genet. 2006, 15: 519-529. 10.1093/hmg/ddi469.CrossRefPubMed
26.
go back to reference Papiol S, Rosa A, Gutiérrez B, Martin B, Salgado P, Catalán R, Arias B, Fañanás L: Interleukin-1 cluster is associated with genetic risk for schizophrenia and bipolar disorder. J Med Genet. 2004, 41: 219-223. 10.1136/jmg.2003.012914.CrossRefPubMed Papiol S, Rosa A, Gutiérrez B, Martin B, Salgado P, Catalán R, Arias B, Fañanás L: Interleukin-1 cluster is associated with genetic risk for schizophrenia and bipolar disorder. J Med Genet. 2004, 41: 219-223. 10.1136/jmg.2003.012914.CrossRefPubMed
27.
go back to reference El-Omar EM, Carrington M, Chow WH, McColl KE, Bream JH, Young HA, Herrera J, Lissowska J, Yuan CC, Rothman N, Lanyon G, Martin M, Fraumeni JF, Rabkin CS: Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature. 2000, 404: 398-402. 10.1038/35006081.CrossRefPubMed El-Omar EM, Carrington M, Chow WH, McColl KE, Bream JH, Young HA, Herrera J, Lissowska J, Yuan CC, Rothman N, Lanyon G, Martin M, Fraumeni JF, Rabkin CS: Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature. 2000, 404: 398-402. 10.1038/35006081.CrossRefPubMed
28.
go back to reference Rahman P, Sun S, Peddle L, Snelgrove T, Melay W, Greenwood C, Gladman D: Association between the interleukin-1 family gene cluster and psoriatic arthritis. Arthritis Rheum. 2006, 54: 2321-2325. 10.1002/art.21928.CrossRefPubMed Rahman P, Sun S, Peddle L, Snelgrove T, Melay W, Greenwood C, Gladman D: Association between the interleukin-1 family gene cluster and psoriatic arthritis. Arthritis Rheum. 2006, 54: 2321-2325. 10.1002/art.21928.CrossRefPubMed
29.
go back to reference The BHF Family Heart Study Research Group: A genomewide linkage study of 1,933 families affected by premature coronary artery disease: the British Heart Foundation (BHF) family heart study. Am J Hum Genet. 2005, 77: 1011-1020. 10.1086/498653.CrossRef The BHF Family Heart Study Research Group: A genomewide linkage study of 1,933 families affected by premature coronary artery disease: the British Heart Foundation (BHF) family heart study. Am J Hum Genet. 2005, 77: 1011-1020. 10.1086/498653.CrossRef
30.
go back to reference Nsengimana J, Samani NJ, Hall AS, Balmforth AJ, Mangino M, Yuldasheva N, Maqbool A, Braund P, Burton P, Bishop DT, Ball SG, Barrett JH, British Heart Foundation Family Heart Study Research Group: Enhanced linkage of a locus on chromosome 2 to premature coronary artery disease in the absence of hypercholesterolaemia. Eur J Hum Genet. 2006, 15: 313-319. 10.1038/sj.ejhg.5201752.CrossRefPubMed Nsengimana J, Samani NJ, Hall AS, Balmforth AJ, Mangino M, Yuldasheva N, Maqbool A, Braund P, Burton P, Bishop DT, Ball SG, Barrett JH, British Heart Foundation Family Heart Study Research Group: Enhanced linkage of a locus on chromosome 2 to premature coronary artery disease in the absence of hypercholesterolaemia. Eur J Hum Genet. 2006, 15: 313-319. 10.1038/sj.ejhg.5201752.CrossRefPubMed
31.
go back to reference Shimasaki Y, Yasue H, Yoshimura M, Nakayama M, Kugiyama K, Ogawa H, Harada E, Masuda T, Koyama W, Saito Y, Miyamoto Y, Ogawa Y, Nakao K: Association of the missense glu298asp variant of the endothelial nitric oxide synthase gene with myocardial infarction. J Am Coll Cardiol. 1998, 31: 1506-1510. 10.1016/S0735-1097(98)00167-3.CrossRefPubMed Shimasaki Y, Yasue H, Yoshimura M, Nakayama M, Kugiyama K, Ogawa H, Harada E, Masuda T, Koyama W, Saito Y, Miyamoto Y, Ogawa Y, Nakao K: Association of the missense glu298asp variant of the endothelial nitric oxide synthase gene with myocardial infarction. J Am Coll Cardiol. 1998, 31: 1506-1510. 10.1016/S0735-1097(98)00167-3.CrossRefPubMed
32.
go back to reference Hingorani AD, Liang CF, Fatibene J, Lyon A, Monteith S, Parsons A, Haydock S, Hopper RV, Stephens NG, O'Shaughnessy KM, Brown MJ: A common variant of the endothelial nitric oxide synthase (glu298->asp) is a major risk factor for coronary artery disease in the UK. Circulation. 1999, 100: 1515-1520.CrossRefPubMed Hingorani AD, Liang CF, Fatibene J, Lyon A, Monteith S, Parsons A, Haydock S, Hopper RV, Stephens NG, O'Shaughnessy KM, Brown MJ: A common variant of the endothelial nitric oxide synthase (glu298->asp) is a major risk factor for coronary artery disease in the UK. Circulation. 1999, 100: 1515-1520.CrossRefPubMed
33.
go back to reference Jachymova M, Horky K, Bultas J, Kozich V, Jindra A, Peleska J, Martasek P: Association of the glu298asp polymorphism in the endothelial nitric oxide synthase gene with essential hypertension resistant to conventional therapy. Biochem Biophys Res Commun. 2001, 284: 426-430. 10.1006/bbrc.2001.5007.CrossRefPubMed Jachymova M, Horky K, Bultas J, Kozich V, Jindra A, Peleska J, Martasek P: Association of the glu298asp polymorphism in the endothelial nitric oxide synthase gene with essential hypertension resistant to conventional therapy. Biochem Biophys Res Commun. 2001, 284: 426-430. 10.1006/bbrc.2001.5007.CrossRefPubMed
34.
go back to reference Shoji M, Tsutaya S, Saito R, Takamatu H, Yasujima M: Positive association of endothelial nitric oxide synthase gene polymorphism with hypertension in Northern Japan. Life Sciences. 2000, 66: 2557-2662. 10.1016/S0024-3205(00)00589-0.CrossRefPubMed Shoji M, Tsutaya S, Saito R, Takamatu H, Yasujima M: Positive association of endothelial nitric oxide synthase gene polymorphism with hypertension in Northern Japan. Life Sciences. 2000, 66: 2557-2662. 10.1016/S0024-3205(00)00589-0.CrossRefPubMed
Metadata
Title
An evaluation of inflammatory gene polymorphisms in sibships discordant for premature coronary artery disease: the GRACE-IMMUNE study
Authors
Benjamin D Brown
Jérémie Nsengimana
Jennifer H Barrett
Richard A Lawrence
Lori Steiner
Suzanne Cheng
D Timothy Bishop
Nilesh J Samani
Stephen G Ball
Anthony J Balmforth
Alistair S Hall
Publication date
01-12-2010
Publisher
BioMed Central
Published in
BMC Medicine / Issue 1/2010
Electronic ISSN: 1741-7015
DOI
https://doi.org/10.1186/1741-7015-8-5

Other articles of this Issue 1/2010

BMC Medicine 1/2010 Go to the issue